Lupin Earns CDP ‘A’ Rating for Climate Change and Water Security

Mumbai, January 24, 2026: Lupin Limited has received the highest ‘A’ leadership rating from the Carbon Disclosure Project (CDP) for its performance in Climate Change and Water Security, marking a significant milestone in the company’s sustainability journey.

The double ‘A’ rating places Lupin among a select group of global companies recognised for leadership in environmental transparency and action. The achievement reflects the company’s strengthened efforts to address climate risks, reduce carbon emissions, and implement responsible water stewardship across its operations.

Lupin’s 2026 ratings represent a notable year-on-year improvement. The company had received ‘A-’ ratings in both Climate Change and Water Security in 2024, following scores of ‘B’ for climate and ‘C’ for water in 2023. The progression highlights consistent enhancements in governance, disclosure quality, and on-ground sustainability initiatives.

Ramesh Swaminathan, Executive Director, Global CFO and Head – API Plus SBU, Lupin, said, “As a global pharma leader, we have significantly advanced our efforts to reduce environmental impact through innovation, collaboration, and transparency. We are proud to have earned CDP’s Double ‘A’ rating. CDP’s strict framework has helped shape and accelerate our climate initiatives, fostering ongoing progress. We are committed to establishing new sustainability standards and generating lasting value for our communities and the planet.”

In addition to the CDP recognition, Lupin has also achieved a strong S&P Global ESG score of 91 in 2025, placing it among a small group of companies worldwide to cross the 90-point benchmark. The combined performance underscores Lupin’s integrated approach to environmental, social, and governance (ESG) priorities.

The CDP ratings are widely regarded as a global benchmark for environmental disclosure and performance, evaluating companies on transparency, risk management, and tangible climate and water actions. Lupin’s leadership rating reinforces its position as a pharmaceutical company advancing sustainability alongside business growth.

*The CDP score referenced is intended for general informational purposes and not for investment decision-making.*